Marksans Pharma Reopens Physical Share Transfer Window

Marksans Pharma Ltd. has announced the re-opening of a special window for the re-lodgement of transfer requests for physical shares. This initiative, in line with SEBI's circular dated January 30, 2026, aims to facilitate investors who had lodged transfer deeds for shares purchased before April 1, 2019, but were rejected or returned due to deficiencies. The window is open for one year, from February 5, 2026, to February 4, 2027. Transferred shares will be credited only in demat mode and will be under a one-year lock-in period. Shareholders need to submit specific documents, and cases involving disputes or IEPF transfers are excluded.